PTH (Parathyroid Hormone) Blood Test

The PTH (Parathyroid Hormone) Blood Test measures parathyroid hormone in the blood. PTH is produced by the parathyroid glands, which are usually four small glands situated behind or close to the thyroid gland in the neck.

Parathyroid hormone plays a central role in regulating calcium and phosphate. It also interacts closely with vitamin D, magnesium, the kidneys, intestines and bones. When blood calcium decreases, the parathyroid glands normally release additional PTH to help restore calcium towards the required level.

The PTH result is most informative when interpreted with calcium measured from a sample collected at approximately the same time. Phosphate, magnesium, vitamin D, creatinine, estimated glomerular filtration rate and urinary calcium may also be required to determine why PTH is elevated or reduced.

The test helps investigate primary, secondary and tertiary hyperparathyroidism, hypoparathyroidism, unexplained high or low calcium, chronic kidney disease–mineral and bone disorder and selected bone or kidney-stone conditions.

Benefits of the PTH Blood Test

• Helps determine the cause of an abnormal blood calcium result.
• Supports the diagnosis of primary hyperparathyroidism.
• Helps identify secondary hyperparathyroidism.
• Supports evaluation for tertiary hyperparathyroidism.
• Helps diagnose reduced parathyroid function or hypoparathyroidism.
• Contributes to monitoring chronic kidney disease–mineral and bone disorder.
• Supports evaluation of recurrent calcium-containing kidney stones.
• Contributes to the investigation of unexplained bone loss or fractures.
• Helps monitor patients following parathyroid surgery.
• Provides information for assessing treatment response over time.

Understanding Parathyroid Hormone

Calcium is essential for bone strength, muscle contraction, nerve signalling, blood clotting and normal heart function. The body therefore controls the concentration of ionised calcium within a narrow physiological range.

When calcium falls, the parathyroid glands release PTH. PTH acts on bones, kidneys and vitamin D metabolism. It increases calcium reabsorption by the kidneys, promotes phosphate excretion and supports the activation of vitamin D in the kidneys.

Active vitamin D increases calcium absorption from the digestive system. PTH can also increase the release of calcium from bone when necessary. When blood calcium rises adequately, PTH secretion normally decreases through a feedback mechanism.

An abnormal PTH concentration may arise from a problem within the parathyroid glands or from another condition that persistently stimulates or suppresses them. The relationship between PTH and calcium is therefore more important than either result in isolation.

What Does the PTH Test Measure?

Most routine assays measure intact parathyroid hormone and may be labelled intact PTH or iPTH. Intact PTH is an 84-amino-acid hormone. Modern immunoassays use antibodies directed against different regions of the PTH molecule to estimate its concentration.

Results are generally reported in picograms per millilitre or an equivalent unit. Reference intervals differ according to the analytical method, laboratory, age and clinical population. The interval printed on the report should always be used.

Kidney function affects PTH metabolism and interpretation. PTH fragments can accumulate when kidney function is significantly reduced, and patients with advanced chronic kidney disease may require disease-stage-specific assessment rather than comparison only with the general adult reference interval.

PTH concentrations can vary during the day and may be influenced by calcium intake, vitamin D status, magnesium, kidney function and some medicines. Serial measurements are most useful when performed using the same laboratory method under reasonably consistent conditions.

Clinical Indications and Applications

High Blood Calcium: PTH is commonly requested when calcium is elevated. High or inappropriately normal PTH in the presence of high calcium suggests a PTH-dependent cause, such as primary hyperparathyroidism.

Low Blood Calcium: Low or inappropriately normal PTH with low calcium may suggest hypoparathyroidism. Elevated PTH with low calcium indicates that the glands are responding but another condition, such as vitamin D deficiency or chronic kidney disease, may be preventing correction.

Primary Hyperparathyroidism: This condition results from autonomous overproduction of PTH by one or more parathyroid glands. A benign parathyroid adenoma is a common cause. Glandular hyperplasia is another cause, while parathyroid cancer is rare.

Secondary Hyperparathyroidism: The glands produce additional PTH in response to a problem outside the parathyroids. Common causes include chronic kidney disease, vitamin D deficiency, low calcium intake and impaired intestinal calcium absorption.

Tertiary Hyperparathyroidism: Long-standing secondary stimulation, particularly in advanced kidney disease, can cause the glands to become autonomous. PTH may remain markedly elevated even when the original stimulus has changed, and calcium may also become elevated.

Hypoparathyroidism: Reduced PTH production may occur after neck surgery, autoimmune damage, genetic conditions, radiation or other injury to the glands. Severe magnesium deficiency can also impair PTH secretion and action.

Bone Disease and Kidney Stones: Excess PTH may increase bone turnover and contribute to reduced bone density. Increased blood and urinary calcium may contribute to kidney-stone formation in selected patients.

Why Doctors Recommend This Test

Calcium abnormalities have many possible causes. PTH helps determine whether the parathyroid glands are responding appropriately. A result described as normal can still be inappropriate when considered with calcium.

For example, PTH should normally be suppressed when blood calcium is high. A PTH result within the laboratory interval may therefore be considered inappropriately normal and support a PTH-dependent disorder when calcium is elevated.

Conversely, PTH should rise when calcium is low. A low-normal result may be physiologically inappropriate in that situation and may indicate reduced parathyroid function.

Patients with chronic kidney disease may develop phosphate retention, reduced active vitamin D and altered calcium balance. These changes stimulate PTH and contribute to chronic kidney disease–mineral and bone disorder, which can affect bones, blood vessels and the cardiovascular system.

Doctors monitor trends rather than relying only on one measurement, especially in chronic kidney disease. Treatment decisions consider calcium, phosphate, vitamin D, alkaline phosphatase, kidney function and the pattern of PTH change over time.

Preparation Before the Test

Fasting requirements vary according to the laboratory and the other tests ordered. Some clinicians prefer morning collection after an overnight fast to standardise the result. Follow the instructions provided when booking the test.

Tell the doctor and laboratory about all prescribed medicines, non-prescription products, calcium supplements, vitamin D, phosphate binders, diuretics, lithium and biotin-containing supplements. Do not stop any treatment without medical advice.

High-dose biotin can interfere with some immunoassays and may produce a misleading result. The doctor or laboratory may advise temporary discontinuation before collection, depending on the dose and analytical method.

Patients receiving dialysis should follow the timing instructions of their nephrologist because the relationship between sample collection and dialysis may affect associated mineral measurements.

When possible, calcium should be measured from a sample collected at approximately the same time. Albumin may also be needed to interpret total calcium, or ionised calcium may be requested when protein binding is abnormal.

Blood Sample Collection Procedure

A trained phlebotomist collects a blood sample from a vein, usually in the arm. The skin is cleaned, a tourniquet is applied and a sterile needle is inserted into the vein. Blood is collected into the tube required by the laboratory.

The procedure generally takes a few minutes. A brief sting, mild bruising or temporary light-headedness may occur. Significant complications are uncommon.

PTH is sensitive to specimen handling. The laboratory follows validated instructions regarding the appropriate sample type, separation, storage and transport. Delayed processing or unsuitable storage can affect the result.

An insufficient, haemolysed, incorrectly labelled or improperly handled specimen may require recollection. Patients undergoing serial monitoring should preferably use the same laboratory when possible to reduce method-related variation.

Laboratory Analysis and Reporting

The laboratory measures PTH using a validated immunoassay, commonly chemiluminescent or electrochemiluminescent technology. The report includes the measured concentration, unit and method-specific reference interval.

Interpretation begins by comparing PTH with calcium. The clinician then reviews phosphate, magnesium, vitamin D and kidney function. A 24-hour urine calcium test or calcium-to-creatinine clearance calculation may be requested in selected patients with hypercalcaemia.

Imaging does not diagnose hyperparathyroidism. Ultrasound, sestamibi scanning or other localisation studies are generally performed after biochemical confirmation when surgery is being considered.

Repeat testing may be needed when the result does not match calcium, symptoms or previous findings. Possible explanations include early disease, vitamin D deficiency, kidney dysfunction, medicine effects, biotin interference or pre-analytical error.

Normal Reporting Time

The report for the PTH (Parathyroid Hormone) Blood Test is generally available within 24 hours after the laboratory receives an acceptable specimen. Actual reporting time may vary according to collection time, laboratory workflow and analytical method.

Tests performed alongside PTH, such as vitamin D or specialised urine investigations, may have different reporting times.

Who Should Consider This Test?

• Patients with elevated blood calcium.
• Patients with low blood calcium.
• Individuals with suspected hyperparathyroidism.
• Patients with possible hypoparathyroidism.
• People with chronic kidney disease.
• Patients with vitamin D deficiency and persistently elevated PTH.
• Individuals with unexplained osteoporosis or fragility fractures.
• Patients with recurrent calcium kidney stones.
• Individuals undergoing evaluation before or after parathyroid surgery.
• Patients specifically referred by an endocrinologist, nephrologist or physician.

Understanding the Test Results

High PTH with High Calcium: This pattern commonly suggests primary hyperparathyroidism. Tertiary hyperparathyroidism and selected medicine-related or inherited conditions may also be considered.

High PTH with Low or Normal Calcium: This may indicate secondary hyperparathyroidism caused by vitamin D deficiency, chronic kidney disease, low calcium intake, impaired absorption or another stimulus. Normocalcaemic primary hyperparathyroidism is considered only after secondary causes are carefully excluded.

Low PTH with Low Calcium: This pattern may suggest hypoparathyroidism. Magnesium deficiency, previous neck surgery, autoimmune disease and genetic conditions may require evaluation.

Low PTH with High Calcium: This suggests that the parathyroid glands are appropriately suppressed and that the hypercalcaemia may be caused by a non-parathyroid condition, such as malignancy, excessive vitamin D or another disorder.

Clinical Limitations

PTH cannot be interpreted accurately without calcium. A result within the reference interval may be physiologically inappropriate depending on whether calcium is high or low.

Kidney dysfunction, vitamin D deficiency, magnesium abnormalities, medicines and high-dose biotin can influence the result or its interpretation. Different PTH assays may produce different numerical values.

The test cannot locate an abnormal parathyroid gland or determine by itself whether surgery is required. Imaging is used for localisation after biochemical diagnosis, not as a replacement for laboratory confirmation.

A single measurement may not reflect the long-term pattern. Repeat testing and evaluation of related minerals may be necessary, particularly in chronic kidney disease.

Important Safety Information

Severe high calcium can cause dehydration, vomiting, marked weakness, confusion, abnormal heart rhythm or reduced consciousness. Severe low calcium can cause tingling, muscle spasms, breathing difficulty, seizures or cardiac rhythm disturbances. These symptoms require urgent medical assessment.

Do not start or stop calcium, vitamin D, phosphate binders or other treatment based only on the PTH result. The result must be reviewed with calcium, kidney function and the complete clinical history by a qualified doctor.